(2E)-N-(3-CYANO-7-ETHOXY-4-((4-(2-PYRIDINYLMETHOXY)PHENYL)AMINO)-6-QUINOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE

UNII:	XCP8UEA4ME
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₀H₃₀N₆O₃
Preferred Substance Name:	(2E)-N-(3-CYANO-7-ETHOXY-4-((4-(2-PYRIDINYLMETHOXY)PHENYL)AMINO)-6-QUINOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE
InChIKey:	MPIQYQIEOBCLFG-VQHVLOKHSA-N
GSRS Full Record:	XCP8UEA4ME i

1469746-91-5
(2E)-N-[3-Cyano-7-ethoxy-4-[[4-(2-pyridinylmethoxy)phenyl]amino]-6-quinolinyl]-4-(dimethylamino)-2-butenamide
2-Butenamide, N-[3-cyano-7-ethoxy-4-[[4-(2-pyridinylmethoxy)phenyl]amino]-6-quinolinyl]-4-(dimethylamino)-, (2E)-
Neratinib Impurity QL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

(2E)-N-(3-CYANO-7-ETHOXY-4-((4-(2-PYRIDINYLMETHOXY)PHENYL)AMINO)-6-QUINOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE

Synonyms and Mappings

Resources